JavaScriptin tulee olla päällä. This page requires JavaScript. Den sida kräver JavaScript.
Psychedelic therapy is a hot topic in the research for the treatment of mood disorders. With several compounds as contenders for FDA approval, the hopes for rapid-acting therapeutics are high. However, is the hype matching the data?
The discussion will be informal. There are no stupid questions, so feel free to share whatever’s on your mind. If you’d rather just listen, that’s perfectly fine too! Coffee and snacks will be served to give a little sugar boost and keep the ideas flowing.
When? December 1, 14-16 (2-4pm)
Where? CP18 Skutsi, P-floor, Biomedicum, Haartmaninkatu 8
Led by Marcel Gil Ortiz & Lauri Elsilä, researchers in neuroscience and pharmacology of psychedelics, University of Helsinki
Paper: Lemarchand at al. Fragile promise of psychedelics in psychiatry. (2024)
https://www.bmj.com/content/bmj/387/bmj-2024-080391.full.pdf
Should you have any questions, please feel free to contact our team (grp-reproducibilitea@helsinki.fi)
Happy reading,
Anastasiia, Julia, Henna, Fatemeh & Vootele